QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response


Show simple item record

dc.contributor.author Esmail, Hanif
dc.contributor.author Thienemann, Friedrich
dc.contributor.author Oni, Tolu
dc.contributor.author Goliath, Rene
dc.contributor.author Wilkinson, Katalin A
dc.contributor.author Wilkinson, Robert J
dc.date.accessioned 2016-11-03T06:37:53Z
dc.date.available 2016-11-03T06:37:53Z
dc.date.issued 2016-10-07
dc.identifier.citation Esmail, H., Thienemann, F., Oni, T., Goliath, R., Wilkinson, K. A., & Wilkinson, R. J. (2016). QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response. BMC Infectious Diseases, 16(1), 545. en_ZA
dc.identifier.issn 1471-2334 en_ZA
dc.identifier.uri http://dx.doi.org/10.1186/s12879-016-1875-6
dc.identifier.uri http://hdl.handle.net/11427/22419
dc.description.abstract Background: HIV-1 infection impairs tuberculosis (TB) specific immune responses affecting the diagnosis of latent TB. We aimed to (1) determine the proportion of HIV-1-infected adults with a negative QuantiFERON®-TB Gold in-tube (QFT-GIT) and Tuberculin skin testing (TST) that convert to QFT-GIT positive following TST, and (2) evaluate the relationship between conversion and baseline QFT-GIT results. Methods: HIV-1 infected adults being screened for a TB vaccine study in South Africa underwent QFT-GIT followed by TST. As per protocol, QFT-GIT was repeated if randomization was delayed allowing for evaluation of TST boosting in a proportion of participants. Results: Of the 22 HIV-1 infected, TST and QFT-GIT negative adults (median CD4 477/mm3 IQR 439–621) who had QFT-GIT repeated after median 62 days (IQR 49–70), 40.9 % (95 % CI 18.6–63.2 %) converted. Converters had a significantly greater increase in the background subtracted TB antigen response (TBAg-Nil – all units IU/mL) following TST, 0.82 (IQR 0.39–1.28) vs 0.03 (IQR −0.05–0.06), p = 0.0001. Those who converted also had a significantly higher baseline TBAg-Nil 0.21(IQR 0.17–0.26) vs 0.02(IQR 0.01–0.07), p = 0.002. Converters did not differ with regard to CD4 count or ART status. ROC analysis showed a baseline cut off of 0.15 correctly classified 86.4 % of converters with 88.9 % sensitivity. Conclusions: Our findings support the possibility that there are 2 distinct groups in an HIV-1 infected population with negative QFT-GIT and TST; a true negative group and a group showing evidence of a weak Mtb specific immune response that boosts significantly following TST resulting in conversion of the test result that may represent false negatives. Further evaluation of whether a lower cut off may improve sensitivity of QFT-GIT in this population is warranted. en_ZA
dc.language eng en_ZA
dc.publisher BioMed Central en_ZA
dc.rights Creative Commons Attribution 4.0 International (CC BY 4.0) *
dc.rights.uri http://creativecommons.org/licenses/by/4.0/ en_ZA
dc.source BMC Infectious Diseases en_ZA
dc.source.uri http://bmcinfectdis.biomedcentral.com/
dc.subject.other Latent tuberculosis
dc.subject.other HIV
dc.subject.other QuantiFERON®-TB Gold in-tube
dc.subject.other Diagnostics
dc.subject.other Interferon Gamma Release Assay
dc.title QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response en_ZA
dc.type Journal Article en_ZA
dc.date.updated 2016-10-07T18:03:05Z
dc.language.rfc3066 en
dc.rights.holder The Author(s).
uct.type.publication Research en_ZA
uct.type.resource Article en_ZA
dc.publisher.institution University of Cape Town
dc.publisher.faculty Faculty of Health Sciences en_ZA
dc.publisher.department Division of Infectious Disease and HIV Med en_ZA
uct.type.filetype Text
uct.type.filetype Image

Files in this item

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International (CC BY 4.0) Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International (CC BY 4.0)